Han and Roman foundthat in NSCLC cell lines, the PPARγ ligands GW1929, 15 dPGJ2, ciglitazone, troglitazone, and rosiglitazone significantly decreased EP2 mRNA andprotein levels causing growth inhibition in NSCLC cells [71]. Here, PPARG is linked to non-small cell lung carcinoma.